Showing results (251-260 of 2,804) with videos related to
Sort By:
Pageof 281
Journal of Crohn'S & Colitis|November 22, 2024
Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel DiseaseAlexandre Mancheron, Agnès Dumas, Isabelle Nion Larmurier, et al.Journal of Crohn'S & Colitis|November 11, 2024
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)Kristina A Holten, Tomm Bernklev, Randi Opheim, et al.Journal of Crohn'S & Colitis|October 16, 2024
Mucosal Cytokine Expression Associated With Deep Endoscopic Mucosal Healing in Ulcerative ColitisKazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima, et al.Journal of Crohn'S & Colitis|September 22, 2024
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical ProgramBruce E Sands, Yvette Leung, David T Rubin, et al.Journal of Crohn'S & Colitis|September 19, 2024
Prolonged Time to Diagnosis of Crohn's Disease in Patients With Perianal Fistulas Negatively Affects Long-Term OutcomesLiesbeth Jozefien Munster, Aagje Johanna Martina Pronk, Marco William Mundt, et al.Journal of Crohn'S & Colitis|October 30, 2024
Considerations in Paediatric and Adolescent Inflammatory Bowel DiseaseStephanie A Vuijk, Anouk E Camman, Lissy de RidderJournal of Crohn'S & Colitis|March 4, 2025
Independent predictors of 90-day readmission in patients with inflammatory bowel disease: a nationwide retrospective studyBryce Kunkle, Harjit Singh, Danielle Abraham, et al.Journal of Crohn'S & Colitis|February 17, 2025
The ulcerative colitis risk gene adenylyl cyclase 7 restrains the T-helper 2 phenotype and Class II antigen presentationChristopher J Cardinale, Yichuan Liu, Aayush Kevadia, et al.Journal of Crohn'S & Colitis|August 30, 2024
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III TrialsRemo Panaccione, Christopher Ma, Vipul Jairath, et al.Journal of Crohn'S & Colitis|June 22, 2024
Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical TrialsCorey A Siegel, Victoria Rai, An Outtier, et al.Pageof 281